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Abstract
Objective: Early HIV diagnosis reduces transmission and improves health outcomes; screening in
non-traditional settings is increasingly advocated. We compared test venues by the number of new
diagnoses successfully linked to the regional HIV treatment center and disease stage at diagnosis.
Methods: We conducted a retrospective cohort study using structured chart review of newly
diagnosed HIV patients successfully referred to the region's only HIV treatment center from 1998
to 2003. Demographics, testing indication, risk profile, and initial CD4 count were recorded.
Results: There were 277 newly diagnosed patients meeting study criteria. Mean age was 33 years,
77% were male, and 46% were African-American. Median CD4 at diagnosis was 324. Diagnoses
were earlier via partner testing at the HIV treatment center (N = 8, median CD4 648, p = 0.008)
and with universal screening by the blood bank, military, and insurance companies (N = 13, median
CD4 483, p = 0.05) than at other venues. Targeted testing by health care and public health entities
based on patient request, risk profile, or patient condition lead to later diagnosis.
Conclusion: Test venues varied by the number of new diagnoses made and the stage of illness at
diagnosis. To improve the rate of early diagnosis, scarce resources should be allocated to maximize
the number of new diagnoses at screening venues where diagnoses are more likely to be early or
alter testing strategies at test venues where diagnoses are traditionally made late. Efforts to
improve early diagnosis should be coordinated longitudinally on a regional basis according to this
conceptual paradigm.
Background
The HIV epidemic continues despite decades of aggressive
prevention efforts and advances in effective treatment. An
estimated one-quarter of those infected remain unaware
of their HIV status, and late diagnosis remains common.
[1-3] Traditional HIV screening that relies on resource-
intensive outreach, or individuals to seek testing, has
failed to fully access at-risk populations. Early diagnosis is
essential to enable opportunities to halt further transmis-
sion [4] and to obtain medical therapy that improves
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morbidity and mortality for infected patients. [5] The
CD4+ T cell count is the accepted marker of disease pro-
gression, and is a surrogate measure of how early in the
disease the diagnosis has been made. [2,3,6,7] CD4+
count declines variably in HIV patients but typically
decreases by an average of 60–100/μL per year [8-10].
Strategies to improve early diagnosis necessarily depend
on who is tested and under what circumstances. Gener-
ally, later diagnosis is associated with diagnostic testing as
a result of illness, while earlier diagnosis is more typical of
patient self-request for testing, self-perceived risk, or uni-
versal screening. [2,11] Modifications to expand universal
screening within health care settings have been proposed.
[12] The CDC initiative particularly encourages screening
in non-traditional settings such as emergency depart-
ments, substance abuse treatment centers, and corrections
facilities. [7,11-14] The resources required to implement
these changes broadly have not yet been allocated.
Understanding the differences between test venues in
terms of numbers of new diagnoses successfully linked to
care and the extent to which those diagnoses are early or
late would inform health care planners on current practice
patterns and resource use. For example, patients who are
seeking HIV testing may self-refer to different venues than
patients who are seeking medical care because of symp-
toms. Prior reports have examined the contributions by
different screening venues to HIV testing. [1,7,13] How-
ever, to our knowledge, variation in stage of diagnosis by
screening venue has not been assessed. To improve rates
of early HIV diagnosis on a regional basis, policy makers
would benefit from an improved understanding of diag-
nosis patterns to inform future allocation of scarce pre-
vention resources.
We hypothesized that diverse regional testing venues
would vary significantly in the number of new diagnoses
made with successful linkage to care and the initial CD4
count of those patients at the time of diagnosis. This study
was designed with the following two objectives, 1) to
determine how many newly diagnosed persons were suc-
cessfully referred by each local test venue relative to the
total number of newly diagnosed persons seen at the
regional HIV treatment center, and 2) to assess the differ-
ences in initial stage of HIV by test venue. We were specif-
ically interested in determining the relative contribution
of a publicly funded emergency department testing pro-
gram to regional patterns of diagnosis.
Methods
Study Design
This was a retrospective cohort study of newly diagnosed
HIV infected persons successfully referred to a regional
infectious disease treatment center between July 1, 1998
and June 31, 2003. The local Institutional Review Board
approved the study.
Setting
Subjects were identified from lists of new patients visiting
the region's only dedicated provider of HIV/AIDS care,
which is located on the campus of an academic hospital
in an urban area. This setting is also uniquely character-
ized by a highly active emergency department HIV screen-
ing program within the university hospital proximate to
the HIV treatment center. [15,16] The surrounding metro-
politan statistical area of approximately 2 million has an
AIDS case rate of 5.7 per 100,000 (2005, HIV Surveillance
report). The surrounding county has a population of
806,652 that is 25% African-American and 1.5% His-
panic.(2005, US Census)
Source Population
The HIV treatment center, called the Infectious Diseases
Center (IDC), provides the vast majority of primary and
consultative care to HIV and AIDS patients in the region.
In 2005, there were 2184 patients known to be living with
HIV/AIDS in the Cincinnati Metropolitan Area (Hamil-
ton, Butler, Warren, Clermont Counties). [17] There were
an estimated additional 245 living in Northern Kentucky
and Western Indiana. Of these not all are in care continu-
ously. In 2007, the IDC saw 1626, or about 67% of those
known to be living with HIV/AIDS in the region. Of the
remainder, the IDC estimates that 300 are seen by others
and 500 are not in care. Overall, it is estimated that the
IDC provides care to about 85% of all HIV and AIDS
patients known to be in care in this region.
Publically available surveillance data on CD4 count at
diagnosis testing venue and facility of diagnosis for the
Cincinnati region are provided by the IDC. The IDC pro-
vides these data to the Ohio Department of Health and
the local health department does not systematically col-
lect any data not reported by the IDC. These data are not
publicly reported by the Ohio Department of Health.
Selection of participants
Records for all patients newly referred to the regional HIV
treatment center during the study period were screened for
inclusion. These logs were created prospectively as new
patients were received by the clinic, but they did not dif-
ferentiate newly referred patients from the subset that
were newly diagnosed. Any person that moves to the
region and seeks care at the IDC is given a new patient
appointment and logged as a new patient. In addition, if
a patient had been seen previously but had been lost to
follow up for 2 years or more, they were similarly consid-
ered a new patient. Thus, the list of new patients main-
tained by the IDC contains many patients who have HIV
but are not newly diagnosed.BMC Public Health 2008, 8:220 http://www.biomedcentral.com/1471-2458/8/220
Page 3 of 11
(page number not for citation purposes)
Patients were included in the study if: 1) their complete
medical record could be located, 2) there was a clinic note
for the first visit, 3) the first visit was within the specified
study period, 4) the patient was HIV positive, and 5) there
was no evidence that the patient had been aware of their
diagnosis more than two months prior to the first visit.
Patient awareness of a prior HIV positive diagnosis was
defined as any acknowledgment of previous treatment,
treatment refusal, or a clear statement in the medical
record suggesting that the patient was aware of their diag-
nosis. Patients were excluded if there was no CD4 evalua-
tion within 60 days of their initial HIV treatment center
appointment.
Data collection
A standardized case report form was used for data abstrac-
tion. Data collected included: 1) patient demographics, 2)
initial CD4 count and viral load within 60 days of initial
visit, 3) venue in which HIV testing was initially done, 4)
reason for HIV testing if noted, and 5) risk factors, symp-
toms, and signs of HIV recorded at the initial visit. Explicit
a priori definitions for abstraction and coding of all data
elements were developed and emphasized during training
of chart abstractors. Variable definitions were not
amended after study initiation. Missing data points were
noted as such after confirmation by a dual abstraction
process.
Chart abstraction used a two stage methodology includ-
ing screening for study enrollment followed by formal
chart abstraction. For screening, three clinical study assist-
ants were trained to review intake visit documentation.
The training period was concluded when study assistants
could classify charts accurately according to inclusion and
exclusion criteria. Each determination of eligibility was
confirmed by the study coordinator until competence was
achieved. At this stage, reviewers were liberal with inclu-
sion; when any doubt existed, the patient was included.
To verify exclusions based on medical records not being
available, charts for each patient were sought on two sep-
arate occasions by two different investigators before being
declared unavailable. Records for every patient included
by the clinical study assistant were secondarily reviewed
by trained research nurses to confirm inclusion criteria
and complete primary data abstraction.
There were 4 research nurses, each with a minimum of 5
years of clinical experience, selected to conduct chart
abstraction. To avoid bias, research nurses were not previ-
ously associated with the HIV treatment center or emer-
gency department screening program, and were blinded
to the study hypothesis. The abstractors were familiarized
with the general format and terminology of the HIV treat-
ment center records with the assistance of the center staff.
Chart abstractors were trained in the study specific chart
abstraction methods and data definitions prior to data
collection by the study investigators. The abstractors
began training by abstracting a series of 5 practice charts,
which were then checked for accuracy both by duplicate
abstraction and by investigator review. This process was
repeated serially until approximately 90% accuracy was
consistently achieved. Monitoring for data quality used
independent dual abstraction of each record with adjudi-
cation of any discrepancies by one of the investigators.
Concordance between abstractors was not statistically
assessed. Ongoing education was conducted whenever
discrepancies occurred to minimize error rate through a
continuous feedback mechanism.
Outcome measures
The main measures are the initial CD4 count and referral
source. Testing venues were grouped according to the
referral center's understanding of each facility's patient
population, funding sources, and testing methods. Medi-
cal testing venues were classified to include inpatient
(hospital), outpatient (primary provider or clinic), emer-
gency departments without dedicated testing programs,
institutional testing done in prisons, substance abuse, and
mental health centers, and medical testing of any
unknown source. Public health testing included the local
health department, Planned Parenthood and a local HIV/
AIDS advocacy, prevention and case-management organi-
zation, which were all funded by the local health depart-
ment to conduct HIV testing. Much of the testing by the
health department and publically funded testing agencies
was either due to self-referral by patients or conducted as
part of evaluation for sexually transmitted infections or
pregnancy. Other venues not classified as health care or
public health testing included a health department
funded HIV counseling and testing program in an emer-
gency department [15,16], a publicly funded partner test-
ing program at the region's HIV treatment center, and
universal screening by the blood bank, military, and
insurance pre-screening. Patients identified outside of the
region or with an unknown referral source were catego-
rized separately. Secondary measures included risk behav-
ior profile and the reason for the testing that lead to
diagnosis, if noted.
Primary Data Processing and Analysis
Completed and adjudicated screening forms and case
report forms were entered in duplicate into electronic for-
mat for subsequent analysis. Prior to analysis, data under-
went a comprehensive cleaning process; each case was
tested for internal consistency and incompatible data ele-
ments were referred back to an independent chart abstrac-
tor for revision or confirmation. Examples of
incompatible data include potentially inconsistent risk
factor information such as a male patient self reporting
sex with men as a risk factor but who also identified as aBMC Public Health 2008, 8:220 http://www.biomedcentral.com/1471-2458/8/220
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heterosexual male. Missing data that could not be located
were declared missing for analysis and are reported as
such.
Summary statistics are used to report the data, medians
and ranges are used for continuous variables and frequen-
cies and proportions are used for categorical variables.
CD4 counts were compared between testing venues using
the Mann-Whitney U test. Analyses were conducted using
SPSS v15.0.1 (SPSS Inc., Chicago, IL) and Microsoft Excel
(Microsoft Corporation, Redmond, WA).
Results
Of 1,226 records for patients newly attending the HIV
treatment center during the study period, 277 unique
patients were newly diagnosed and determined to meet
study criteria. Reasons for exclusion are shown in Figure 1.
Overall, included patients had a median age of 33 years
(range 17 to 77 years), were 76% male, 46% African-
American, and are described in Table 1. There were 143
patients identified through medical testing and 75 diag-
nosed by public health testing. Most medical outpatient
settings referring newly diagnosed patients were either
hospital affiliated primary care clinics or publically
funded clinics and health centers in relatively close geo-
graphic proximity to the study site. Of those patients
tested in these outpatient settings, 29 (34.5%) were pri-
vately insured, 4 (4.8%) had Medicare, 14 (16.7%) had
Medicaid, 5 (6%) had some other form of public assist-
ance, and 32 (38.1%) had no medical insurance. Other
venues not classified as health care or public health testing
included a health department funded HIV counseling and
testing program in an emergency department [15,16] (n =
23), a publicly funded partner testing program at the
region's HIV treatment center (n = 8), and universal
screening by the blood bank, military, and insurance pre-
screening (n = 13). Two patients were identified outside of
the region and 13 were from an unknown referral source.
Overall, there were 129 patients (46.6%) diagnosed early
with a CD4 greater than 350, and 104 (37.5%) diagnosed
late with a CD4 less than 200. The median values for ini-
tial CD4 count are shown in Figure 2. There were no dif-
ferences in HIV viral load by site of diagnosis (data not
shown). Partner testing by the IDC (median CD4 648/μL)
and universal screening (median CD4 483/μL) identified
patients earlier in their disease course than testing in other
venues (partner testing v all others, p = 0.008 and univer-
sal screening v all others, p = 0.05). While inpatient testing
contributed a large number of new diagnoses, it predom-
inately identified patients with more advanced HIV dis-
ease (median CD4 24/μL, v all others p < 0.001).
Table 2 describes the reasons for testing for each referral
source. Generally, testing because of symptoms or AIDS
defining illness was more common at those venues that
contributed predominately to later diagnoses. The emer-
gency department testing program, in accordance with
program design and setting, tested both for purposes of
diagnosis and according to patient risk and patient self-
request. Thus, amongst those with recorded reasons for
testing in the emergency department; roughly half were
for symptoms consistent with AIDS (7/9 had a CD 4 count
< 350/μL) and half were based on risk factors or patient
request (6/10 had a CD4 count > 350/μL).
The number of new cases identified by each setting was
plotted against the median CD4 count of newly diag-
nosed patients in Figure 3. With the exception of health
department and medical outpatient testing, the results
show that settings identifying patients earlier contributed
fewer total cases, whereas later diagnosis by hospital test-
ing contributed significantly to the total number of newly
identified patients.
Discussion
To our knowledge this is the first regional assessment
comparing testing venues by the number of newly diag-
nosed patients and the stage of illness at diagnosis for
patients successfully linked to subsequent care. As
hypothesized, the number and timing of new HIV diag-
noses are variably distributed. Our data demonstrate a
mismatch between stage of diagnosis and what is optimal
for public health goals; many newly identified HIV
patients were diagnosed later as a result of diagnostic test-
ing and too few were identified early enough through
screening. This conceptual framework affirms the recent
changes to the guidelines for testing in healthcare settings.
[12] On a regional and national basis, progress towards
earlier patterns of HIV diagnosis would be expected to
occur if available resources were shifted for maximal
effect. Screening by those venues with a track record of
earlier diagnoses could be increased provided the addi-
tional resources would be effectively translated into a sim-
ilar pattern of success. In settings where diagnoses are
typically later, it might be possible to modify testing
methods in a manner that would promote earlier diagno-
sis. Alternatively, resources might be shifted from screen-
ing in late diagnosing venues in favor of those providing
earlier diagnoses, although diagnostic testing in such set-
tings would presumably still be encouraged. Serial evalu-
ations such as the one provided here or as provided by
name-based HIV case surveillance could directly assess the
effects of strategic planning by local, state, and national
health officials. Regardless of the source of such data,
monitoring new HIV diagnoses, linkage to care, and CD4
count at the time of diagnosis by testing venue should be
an increasingly emphasized and utilized component of
prospective surveillance efforts. With such a strategy it
becomes possible to assess the extent to which patterns ofBMC Public Health 2008, 8:220 http://www.biomedcentral.com/1471-2458/8/220
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Reasons for Exclusion of Potential Study Subjects Figure 1
Reasons for Exclusion of Potential Study Subjects.B
M
C
 
P
u
b
l
i
c
 
H
e
a
l
t
h
 
2
0
0
8
,
 
8
:
2
2
0
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
4
5
8
/
8
/
2
2
0
P
a
g
e
 
6
 
o
f
 
1
1
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 1: Demographic and Risk Behavior Profile with Categorization by Testing Venue.
Medical testing Public health testing Other testing
Inpatient Outpatient Emergency 
department
Unknown 
source
Institutional 
testing
Health 
department
Publicly 
funded 
programs
ED testing 
program
Identified 
outside the 
region
IDC/Partner 
testing
Routine 
screening
Unknown Total
N = 37 N = 84 N = 5 N = 7 N = 10 N = 70 N = 5 N = 23 N = 2 N = 8 N = 13 N = 13 N = 277
Age (years) 39 22–68 31.5 19–77 33 27–51 33 18–44 34 23–45 34 17–60 27 21–46 32 19–43 28.5 26–31 29 19–57 27 17–43 34 20–50 33 17–77
Black 19 51.4 49 58.3 3 60.0 1 14.3 8 80.0 21 30.0 2 40.0 12 52.2 1 50.0 1 12.5 5 38.5 5 38.5 127 45.8
White 14 37.8 30 35.7 2 40.0 6 85.7 2 20.0 41 58.6 3 60.0 11 47.8 0 0.0 7 87.5 8 61.5 8 61.5 132 47.7
Other 1 2.7 4 4.8 0 0.0 0 0.0 0 0.0 5 7.1 0 0.0 0 0.0 1 50.0 0 0.0 0 0.0 0 0.0 11 4.0
Hispanic 3 8.1 1 1.2 0 0.0 0 0.0 0 0.0 3 4.3 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 7 2.5
Male 30 81.1 48 57.1 4 80 5 71.4 9 90 61 87.1 3 60 22 95.7 1 50 7 87.5 12 92.3 9 69.2 211 76.2
Female 7 18.9 36 42.9 1 20 2 28.6 1 10 9 12.9 2 40 1 4.3 1 50 1 12.5 1 7.7 4 30.8 66 23.8
Injection drug use (IDU) 0 0.0 8 9.5 0 0.0 1 14.3 3 30.0 2 2.9 0 0.0 1 4.3 0 0.0 0 0.0 0 0.0 1 7.7 16 5.8
Male-male sex 13 35.1 30 35.7 3 60.0 3 42.9 4 40.0 48 68.6 2 40.0 12 52.2 0 0.0 6 75.0 7 53.8 9 69.2 137 49.5
STD diagnosis 7 18.9 22 26.2 2 40.0 0 0.0 3 30.0 24 34.3 1 20.0 7 30.4 1 50.0 1 12.5 4 30.8 1 7.7 73 26.4
Sex for drugs/money 1 2.7 2 2.4 0 0.0 0 0.0 1 10.0 0 0.0 0 0.0 1 4.3 0 0.0 0 0.0 1 7.7 1 7.7 7 2.5
Transfusion/transplant 0 0.0 2 2.4 0 0.0 1 14.3 0 0.0 1 1.4 0 0.0 2 8.7 1 50.0 0 0.0 1 7.7 0 0.0 8 2.9
Sex with an at-risk 
partner
3 8.1 14 16.7 0 0.0 3 42.9 0 0.0 22 31.4 1 20.0 7 30.4 0 0.0 8 100.0 1 7.7 2 15.4 61 22.0
Victim of sexual assault 1 2.7 3 3.6 0 0.0 0 0.0 0 0.0 2 2.9 0 0.0 1 4.3 2 100.0 1 12.5 0 0.0 0 0.0 10 3.6
Multiple partners 11 29.7 33 39.3 2 40.0 2 28.6 5 50.0 27 38.6 1 20.0 15 65.2 1 50.0 2 25.0 2 15.4 6 46.2 107 38.6
Heterosexual contact 
only
5 13.5 8 9.5 2 40.0 1 14.3 1 10.0 1 1.4 0 0.0 1 4.3 0 0.0 0 0.0 2 15.4 1 7.7 22 7.9
No risk specified 8 21.6 6 7.1 0 0.0 1 14.3 0 0.0 1 1.4 0 0.0 0 0.0 0 0.0 0 0.0 1 7.7 1 7.7 18 6.5
CD4 24 0–647 312 0–1063 293 69–731 425 12–1135 365 22–704 421 0–1299 347 0–1100 276 11–1756 352 212–492 648 12–1517 483 102–711 424 11–862 324 0–1756
Characteristics of newly diagnosed HIV patients presenting to the infectious disease center are shown with stratification by type of setting in which diagnosis occurred. The frequency and percentage of total 
sample is given, with the exception of age and CD4 where median value and range are provided. Patients could have multiple risk factors identified. Risk factors do not necessarily indicate the reason for 
testing by the setting in which the diagnosis occurred.BMC Public Health 2008, 8:220 http://www.biomedcentral.com/1471-2458/8/220
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resource allocation for screening and testing match pat-
terns of early diagnosis and linkage of HIV positive
patients to care without detailed investigation or report-
ing from every possible testing facility.
Our setting and study design was advantageous for a vari-
ety of reasons. There is a low to moderate prevalence of
HIV, making results generalizable to a wide number of set-
tings that are likely to renew and expand HIV prevention
efforts after the release of the 2006 CDC guidelines for
HIV testing in healthcare settings. [12] While representing
an urban area of considerable size, the vast majority of
HIV positive patients in the region are cared for by a single
HIV treatment center. There is a highly active emergency
department based HIV screening program in the area,
allowing preliminary assessment of the potential impor-
tance of recently expanded CDC emphasis on emergency
departments. [11,12] Our study design allowed a rela-
tively robust sample size without the time and expense
required to construct a prospective surveillance system.
Also, duplication of new diagnoses by testing the same
patient in different care settings was not a factor.
A primary limitation of our work is the use of records from
an HIV treatment center to identify study subjects. Our
analysis only indirectly equates testing venue with the
testing strategies employed by those venues. Our methods
did not assess the total number of tests performed or the
costs of service provided for any venues. Similarly, we can-
not account for diagnosed patients who never received
their results or were not linked to the regional specialty
care clinic. Some of these patients may have remained in,
or been linked to, an alternative and appropriate patient-
provider relationship. Because advanced illness would
Initial CD4 and Viral Load Measures Figure 2
Initial CD4 and Viral Load Measures. Box and whisker plots of the initial CD4 count and viral load are shown with cate-
gorization by testing venue. The boxes represent the interquartile range, the bar within the boxes represents the median value. 
The whiskers represent the limit for outliers, shown as circles (o), defined as values falling between 1.5 and 3 box lengths from 
the end of the box. Cases shown as stars (*) are extreme values, defined as greater than 3 box lengths from the end of the box. 
The horizontal dotted line across represents a CD4 level of 350 (/μL).B
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Table 2: Reasons for HIV Testing
Medical testing Public health testing Other testing Unknown
Inpatient Outpatient Emergency 
department
Unknown 
source
Institutional 
testing
Health 
department
Publicly 
funded 
programs
ED testing 
program
Identified 
outside the 
region
IDC/Partner 
testing
Routine 
screening
N = 37 N = 84 N = 5 N = 7 N = 10 N = 70 N = 5 N = 23 N = 2 N = 8 N = 13 N = 13
Not specified 11 29.7 24 28.6 2 40.0 1 14.3 4 40.0 23 32.9 4 80.0 4 18.2 0 0.0 0 0.0 1 7.7 9 69.2
Patient request 1 2.7 2 2.4 1 20.0 0 0.0 1 10.0 12 17.1 0 0.0 8 36.4 0 0.0 0 0.0 0 0.0 0 0.0
Universal screening 1 2.7 20 23.8 0 0.0 2 28.6 3 30.0 2 2.9 1 20.0 1 4.5 2 100.0 1 12.5 11 84.6 1 7.7
Reasons specified in record 24 64.9 38 45.2 2 40.0 4 57.1 2 20.0 33 47.1 0 0.0 9 40.9 0 0.0 7 87.5 1 7.7 3 23.1
Related diagnosis 1 4.2 4 10.5 0 0.0 0 0.0 0 0.0 1 3.0 2 22.2 0 0.0 0 0.0 0 0.0
AIDS defining illness 7 2 9 . 2 25 . 300 . 000 . 000 . 000 . 0 1 1 1 . 1 00 . 000 . 0 0 0 . 0
Symptoms 8 33.3 16 42.1 2 100.0 0 0.0 1 50.0 8 24.2 3 33.3 0 0.0 0 0.0 1 33.3
Symptoms and related diagnosis 0 0 . 012 . 600 . 000 . 000 . 000 . 0 00 . 0 00 . 000 . 0 0 0 . 0
Symptoms and AIDS defining illness 6 25.0 4 10.5 0 0.0 1 25.0 1 50.0 1 3.0 2 22.2 1 14.3 0 0.0 0 0.0
Symptoms, related diagnosis, AIDS 
defining illness
1 4 . 212 . 600 . 000 . 000 . 013 . 0 00 . 0 00 . 000 . 0 0 0 . 0
Risk factors only 0 0.0 6 15.8 0 0.0 2 50.0 0 0.0 18 54.5 1 11.1 5 71.4 1 100.0 2 66.7
Risk factors with related diagnosis 1 4 . 212 . 600 . 000 . 000 . 000 . 0 00 . 0 00 . 000 . 0 0 0 . 0
Risk factors with symptoms 0 0.0 2 5.3 0 0.0 1 25.0 0 0.0 3 9.1 0 0.0 1 14.3 0 0.0 0 0.0
Risk factors, Symptoms, related 
diagnosis, AIDS defining illness
0 0 . 012 . 600 . 000 . 000 . 013 . 0 00 . 0 00 . 000 . 0 0 0 . 0
The reason why the patient was tested as recorded at initial infectious disease treatment center visit are displayed and categorized by testing venue. Data are given as numbers and percentages. Reasons 
for testing were subcategorized as patient request, universal screening, symptoms suggestive of HIV, diagnosis potentially related to HIV, AIDS defining illness, and HIV behavioral risk factors. These 
categories are presented individually and in combination.BMC Public Health 2008, 8:220 http://www.biomedcentral.com/1471-2458/8/220
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more reliably lead to contact with the HIV treatment
center, our inclusion criteria would be biased in favor of
those with advanced illness; the net result would be a
greater representation of diagnoses arising from settings
that test late in the course of illness, such as hospitals.
Another important limitation of our work is that direct
assessment of screening versus diagnostic testing was not
possible. Nonetheless, we have broadly grouped testing
venues by the patterns of testing and patient populations
that are likely to have been present during the study
period. We suggest that these patterns mirror what is likely
the case on a national basis. Testing by medical providers
in the absence of dedicated screening efforts is likely to be
primarily based on signs and symptoms of illness. This
diagnostic testing has been consistently shown to lead to
later diagnosis. [2,11] Not surprisingly, testing by hospi-
tals was especially likely to identify patients with sympto-
matic HIV and very low initial CD4+ counts. Testing by
publicly funded programs is far more likely to be a result
of screening based on patient request or recognized risk
factors, and accordingly leads to earlier diagnosis than
diagnostic testing [2,11].
The inclusion criteria of our study may also be subject to
scrutiny. We assumed all patients to be newly diagnosed
if there was no direct indication to the contrary. Several
patients could have tested positive months or even years
prior to the positive test that ultimately led them to the
infectious disease center. This too would bias our results
Number of Newly Diagnosed HIV Positive Patients and Stage of Illness at Diagnosis for Regional HIV Test Venues Figure 3
Number of Newly Diagnosed HIV Positive Patients and Stage of Illness at Diagnosis for Regional HIV Test 
Venues. The number of cases identified at each test setting is plotted against the median CD4 count at that setting. Labels are 
shown above or to the right of the corresponding data point. The best case scenario is a program with a high number of cases 
identified with a high median CD4 count (i.e. in the top right portion of the figure).BMC Public Health 2008, 8:220 http://www.biomedcentral.com/1471-2458/8/220
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in favor of later diagnosis. However, if there is no chart
record of prior tests, patient awareness of those tests, or
medical care based on those tests, then the importance of
prior testing, even if it did occur, may be suspect. In this
sense, a repeat positive test might still be considered a new
diagnosis if it led to subsequent actions where there had
been none previously.
The emergency department program was considered sep-
arately due to its unique approach. During the study
period, this emergency department program was the only
known healthcare setting with a large scale dedicated
screening effort. Notably this program was funded by the
local health department and involved health counselor
screening for HIV risk. [15,16] However, the setting also
provided access to patients with acute medical illness and
accepted referrals from medical providers for testing based
on signs and symptoms potentially suggestive of HIV.
Overall, the median CD4 for the emergency department
screening program was lower than anticipated, both in
absolute terms and relative to other regional screening
efforts. While this finding prompts many questions, it
should not be interpreted as inhibitory to the increased
interest in emergency department based HIV testing.
Because emergency departments see both acutely ill
patients and disadvantaged populations that seek emer-
gency department care for more routine health needs, it is
likely that diagnosis will result from both diagnostic test-
ing leading to late diagnosis and screening leading to early
diagnosis. Indeed, among those patients for whom a test-
ing indication was recorded, roughly half were for symp-
toms consistent with AIDS and half were based on risk
factors or patient request. It is also notable that, despite
the support of the local health department, available
resources allowed only a small proportion of the eligible
emergency department population to be tested [15,16].
Patients diagnosed by the HIV treatment center had an
exceptionally high median CD4 count. This testing pro-
gram was targeted towards partners of HIV patients cared
for at the clinic. At the time, this program was also funded
by the local health department. When fully contextualized
with markers of early diagnosis, the partner testing pro-
gram is compelling. Our results further support the
importance of partner testing programs.
There were several sources of universal screening during
the study period, including insurance pre-screening,
screening prior to entering military service, and blood
bank surveillance. Blood bank surveillance is a unique
contributor to the HIV prevention picture. The blood
bank attempts to remove the majority of at-risk patients
prior to donation, but then routinely tests all donations to
ensure the safety of the blood supply. This is entirely dif-
ferent than other testing which is aimed at seeking undi-
agnosed HIV positive persons. It is therefore expected that
the number of positive patients identified by the blood
bank will be small in absolute number, but that those
diagnosed will be diagnosed early and well before symp-
toms of illness develop, an expectation that our data sup-
ports.
Our findings should be interpreted in light of several lim-
itations in addition to those already noted. Although we
anticipated only 200 patients and actually identified 277,
there were 362 of 1278 potential records that could not be
located. If any missed records were randomly allocated
between disease severity and referral source then it would
have little effect on our primary analyses other than to
reduce sample size. The low regional prevalence addition-
ally contributes to the small sample size of some referral
subgroups. Our chart review methods were rigorous, but
data such as the original reason for testing or even the test-
ing venue was frequently unavailable. There were also 14
patients excluded since they did not have a CD4+ count
measured proximate to their time of diagnosis.
Conclusion
Our data show that among patients linked to care at this
referral center, many newly identified persons with HIV
are diagnosed late, and the extent to which they were
likely to have been diagnosed late varied by the facility in
which they were diagnosed. Many of these patients were
tested in healthcare settings due to a medical suspicion for
HIV infection. Screening programs with demonstrated
potential to identify patients with HIV early in their dis-
ease course contributed less. This is the inverse of what is
desirable. This suggests that monitoring of core outcomes,
including initial CD4 and linkage to care by testing venue,
is a critical consideration when allocating resources. We
provide a conceptual paradigm for use when resources are
insufficient to maximize testing in all possible ways; set-
tings that generally diagnose HIV positive patients late in
their disease course should either modify methods to aug-
ment earlier diagnosis or be de-emphasized as a focus of
coordinated screening efforts in favor of other venues. Set-
tings that typically provide early identification should
receive additional support provided that support trans-
lates to an increased absolute number of new diagnoses.
Emergency department testing can contribute signifi-
cantly to regional diagnosis patterns, but the extent to
which that contribution is early will depend upon the
strategies utilized. Markers of early diagnosis must be
tracked by screening programs and policy makers to qual-
ity assure prevention efforts and coordinate prevention
activities on a regional level.
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